G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling
- PMID: 14715532
- DOI: 10.1161/01.RES.0000110420.68526.19
G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling
Abstract
The cardiovascular system is richly endowed with G protein-coupled receptors (GPCRs), members of the largest family of plasma membrane-localized receptors. During the last 10 years, it has become increasingly clear that many, if not all, GPCRs function in oligomeric complexes, as either homo- or hetero-oligomers. This review explores the mechanistic implications of GPCR dimerization and/or oligomerization on receptor activation and interactions with G proteins. The effects of GPCR oligomerization on receptor pharmacology, GPCR-mediated signaling, and potential contributions to GPCR crosstalk will be considered in the context of receptors important in the cardiovascular system. Our evolving understanding of the structural and functional consequences of GPCR oligomerization may provide novel and more selective sites for pharmacological tuning of cardiovascular function.
Similar articles
-
Characterization of GRK2 RH domain-dependent regulation of GPCR coupling to heterotrimeric G proteins.Methods Enzymol. 2004;390:310-36. doi: 10.1016/S0076-6879(04)90020-1. Methods Enzymol. 2004. PMID: 15488186
-
The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.Curr Opin Drug Discov Devel. 2005 Sep;8(5):577-84. Curr Opin Drug Discov Devel. 2005. PMID: 16159019 Review.
-
Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions.J Endocrinol. 2008 Mar;196(3):435-53. doi: 10.1677/JOE-07-0573. J Endocrinol. 2008. PMID: 18310440 Review.
-
Trafficking of G protein-coupled receptors.Circ Res. 2006 Sep 15;99(6):570-82. doi: 10.1161/01.RES.0000242563.47507.ce. Circ Res. 2006. PMID: 16973913
-
G-protein-coupled receptor heterodimerization: assay technologies to clinical significance.Curr Opin Drug Discov Devel. 2007 Sep;10(5):580-9. Curr Opin Drug Discov Devel. 2007. PMID: 17786857 Review.
Cited by
-
A method for the prediction of GPCRs coupling specificity to G-proteins using refined profile Hidden Markov Models.BMC Bioinformatics. 2005 Apr 22;6:104. doi: 10.1186/1471-2105-6-104. BMC Bioinformatics. 2005. PMID: 15847681 Free PMC article.
-
Opposite regulation of Slick and Slack K+ channels by neuromodulators.J Neurosci. 2006 May 10;26(19):5059-68. doi: 10.1523/JNEUROSCI.3372-05.2006. J Neurosci. 2006. PMID: 16687497 Free PMC article.
-
Disruption of Rhodopsin Dimerization with Synthetic Peptides Targeting an Interaction Interface.J Biol Chem. 2015 Oct 16;290(42):25728-44. doi: 10.1074/jbc.M115.662684. Epub 2015 Sep 1. J Biol Chem. 2015. PMID: 26330551 Free PMC article.
-
Supramolecular Organization As a Factor of Ribonuclease Cytotoxicity.Acta Naturae. 2020 Jul-Sep;12(3):24-33. doi: 10.32607/actanaturae.11000. Acta Naturae. 2020. PMID: 33173594 Free PMC article.
-
Enhanced targeting with heterobivalent ligands.Mol Cancer Ther. 2009 Aug;8(8):2356-65. doi: 10.1158/1535-7163.MCT-08-1183. Epub 2009 Aug 11. Mol Cancer Ther. 2009. PMID: 19671749 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources